Dudediligence.

Inhibrx Biosciences, Inc

INBXNASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Insiders

Last 12 months

Sales planned on beside the trades reported on , and whether each names a .

Planned ·

$279,010

5 notices · 2,500 sh

Oct 2025 to Oct 2026

Reported ·

$11.3M

3 sales · 0 buys

Oct 2025 to Jun 2026

The two figures cover different periods.

None of the 3 reported sales carry the 10b5-1 box. Together they are 2.38% of the shares on issue.

PLANNED · FORM 144Oct 2025 to Oct 2026REPORTED · FORM 4Oct 2025 to Jun 2026N2025DJ2026FMAMJJASO2026-09-15: MANHARD KIMBERLY, Form 1442026-09-14: MANHARD KIMBERLY, Form 1442026-09-11: MANHARD KIMBERLY, Form 1442026-09-09: MANHARD KIMBERLY, Form 1442026-09-08: MANHARD KIMBERLY, Form 1442025-10-07: VIKING GLOBAL INVESTORS LP, sold
under a no plan named▼ salesize is dollars

Form 144 notices, newest first

2026-09-15MANHARD KIMBERLY, Director$52,525
500 shno plan dateForm 4s on file end Jun 23144 ↗
2026-09-14MANHARD KIMBERLY, Director$55,130
500 shno plan dateForm 4s on file end Jun 23144 ↗
2026-09-11MANHARD KIMBERLY, Director$55,888
500 shno plan dateForm 4s on file end Jun 23144 ↗
2026-09-09MANHARD KIMBERLY, Director$57,898
500 shno plan dateForm 4s on file end Jun 23144 ↗
2026-09-08MANHARD KIMBERLY, Director$57,570
500 shno plan dateForm 4s on file end Jun 23144 ↗